This Policy aims to set out the provisions with the objectives of ensuring that the shareholders of the Company, both individual and institutional (“Shareholders”), and in appropriate circumstances, the investment community at large, are provided with ready, equal and timely access to balanced and understandable information relating to the financial performance, strategic goals and plans, material developments, corporate governance issues of the Company.
The Board shall maintain an on-going dialogue with Shareholders and the investment community, regularly review this Policy to ensure its effectiveness.
Information shall be communicated to Shareholders and the investment community mainly through the Company’s financial reports, and announcements, annual general meetings and other general meetings that may be convened, as well as by making available all the disclosures submitted to The Stock Exchange of Hong Kong Limited (“HKEx”) and its corporate communications and other corporate publications on the website of the Company.
Effective and timely dissemination of information to Shareholders and the investment community shall be ensured at all times.Any queries regarding this Policy shall be directed to the Company Secretary.
Corporate Communications will be provided to Shareholders in plain language in both English and Chinese to facilitate Shareholders’ understanding
Corporate Communications refer to any document issued or to be issued by the Company for the information or action of holders of its securities, including, but not limited to, the directors’ report and annual accounts together with a copy of the independent auditors’ report, the interim report, a notice of meeting, circular and a proxy form.
Investor Relations section is available on the website of the Company ( www.sinopharmtech.com.hk ) for providing corporate information.Information on the Company’s website is updated on a regular basis.
Information released by the Company to HKEx is also posted on the website of the Company, including financial statements, results announcements, circulars, notices of general meetings, etc.
All press releases issued by the Company will be made available on the website of the Company.
Shareholders should direct their questions about their shareholdings to Company’s Registrar in Hong Kong, Tricor Standard Limited.
Shareholders and investment community may at any time make a request for the information of the Company to the extent such information is publicly available.
For enquiries, please refer to the contacts under “Contact Us” section on the website of the Company ( www.sinopharmtech.com.hk ).
Shareholders are encouraged to participate in general meetings or to appoint proxies to attend and vote at the meetings for and on behalf if they are unable to attend the meetings.
The Chairman will allow reasonable time during the general meetings for questions and comments from Shareholders. Appropriate arrangements for the general meetings shall be in place to encourage Shareholders’ participation.
The process of the Company's general meetings will be monitored and reviewed on a regular basis, and, if necessary, changes will be made to ensure that Shareholders' needs are best served.
Board members, in particular, either Chairman or the chairman of Board committees or their delegates, appropriate management executives and external auditors will attend annual general meetings to answer Shareholders' questions.
Investor/analysts briefings and one-on-one meetings, roadshows, media interviews, marketing activities for investors, specialist industry forums, etc. will be available on a regular basis for facilitating communication between the Company, Shareholders and the investment community.
The Company recognizes the importance of Shareholders’ privacy and will not disclose Shareholders’ information without their consent, unless required by law, rules and/ or regulations to do so.